This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Feb;14(1):11.

doi: 10.1136/ebm.14.1.11.

A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes

Arsh K Jain¹, Matthew A Weir

Affiliations

PMID: 19181943
DOI: 10.1136/ebm.14.1.11

Comment

A combination of telmisartan and ramipril increased renal outcomes in vascular disease or diabetes

Arsh K Jain et al. Evid Based Med. 2009 Feb.

. 2009 Feb;14(1):11.

doi: 10.1136/ebm.14.1.11.

Authors

Arsh K Jain¹, Matthew A Weir

Affiliation

¹ University of Western Ontario London, Ontario, Canada.

PMID: 19181943
DOI: 10.1136/ebm.14.1.11

No abstract available

PubMed Disclaimer

Comment on

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators. Mann JF, et al. Lancet. 2008 Aug 16;372(9638):547-53. doi: 10.1016/S0140-6736(08)61236-2. Lancet. 2008. PMID: 18707986 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.